Abstract
Primary hyperparathyroidism (PHPT) is a common endocrine disorder that especially affects women over 50–60 years [1]. The combination of increased serum calcium and parathyroid hormone (PTH) concentrations confirms the diagnosis. Surgery is the only potentially curative treatment, and there is universal agreement regarding which patients should be referred for surgery and for whom surveillance is sufficient. If the patient is scheduled for surgery, preoperative localization of the abnormal parathyroid gland(s) should be performed in order to help the surgeon plan the surgical strategy. It has been estimated that 60–70 % of patients with PHPT are candidates for unilateral neck exploration. If surgery is not planned, there is no reason to perform preoperative localization studies. Preoperative localization studies are mandatory before reoperation of PHPT. Multiple localization studies are to date available and they can be divided into invasive and noninvasive techniques. Surgery should not be ruled out based on a negative preoperative imaging study. For such cases, bilateral neck exploration is performed as primary surgery.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Pallan S, Rahman MO, Khan AA (2012) Diagnosis and management of primary hyperparathyroidism. BMJ 344:e1013
Adami S, Marcocci C, Gatti D (2002) Epidemiology of primary hyperparathyroidism in Europe. J Bone Mineral Res 17(suppl 2):N18–23
Eastell R, Brandi ML, Costa AG et al (2014) Diagnosis of asymptomatic primary hyperparathyroidism: proceedings of the fourth International workshop. J Clin Endocrinol Metab 99:3570–3579
Korpi-Hyövälti E, Cranston T, Ryhänen E et al (2014) CDC73 intragenic deletion in familial primary hyperparathyroidism associated with parathyroid carcinoma. J Clin Endocrinol Metab 99:3044–3048
Lassen T, Friis-Hansen L, Rasmussen ÅK et al (2014) Primary hyperparathyroidism in young people. When should we perform genetic testing for multiple endokrine neoplasia 1 (MEN-1)? J Clin Endocrinol Metab 99:3983–3987
Udelsman R, Åkerström G, Biagini C et al (2014) The surgical management of asymptomatic primary hyperparathyroidism: proceedings of the fourth International workshop. J Clin Endocrinol Metab 99:3595–3606
Khan A, Bilezikian J (2000) Primary hyperparathyroidism: pathophysiology and impact on bone. CMAJ 163:184–187
Khan AA, Bilezikian JP, Potts JT Jr (2009) The diagnosis and management of asymptomatic primary hyperparathyroidism revisited. J Clin Endocrinol Metab 94:333–334
Bilezikian JP, Brandi ML, Eastell R et al (2014) Guidelines for the management of asymptomatic primary hyperparathyroidism: summary statement from the fourth international workshop. J Clin Endocrinol Metab 99:3561–3569
Ryhänen EM, Schildt J, Heiskanen I et al (2015) 99mTechnetium sestamibi-123Iodine scintigraphy is more accurate than 99mTechnetium sestamibi alone before surgery for primary hyperparathyroidism. Int J Mol Imaging 2015:391625
Schalin-Jäntti C, Ryhänen E, Heiskanen I et al (2013) Planar scintigraphy with 123I/99mTc-sestamibi, 99mTc-sestamibi SPECT/CT, 11C-methionine PET/CT, or selective venous sampling before reoperation of primary hyperparathyroidism? J Nucl Med 54:739–747
Cheung K, Wang TS, Farrokhyar F et al (2012) A meta-analysis of preoperative localization techniques for patients with primary hyperparathyroidism. Ann Surg Oncol 19:577–583
Reitz RE, Pollard JJ, Wang CA et al (1969) Localization of parathyroid adenomas by selective venous catheterization and radioimmunoassay. N Engl J Med 281:348–351
Granberg PO, Hamberger B, Johansson G et al (1986) Selective venous sampling for localization of hyperfunctioning parathyroid glands. Br J Surg 73:118–120
Coakley AJ, Kettle AG, Wells CP et al (1989) 99Tcm sestamibi – a new agent for parathyroid imaging. Nucl Med Commun 10:791–794
Greenspan BS, Dillehay G, Intenzo C et al (2012) SNM practice guideline for parathyroid scintigraphy. J Nucl Med Technol 40:111–118
Hindie E, Ugur Ö, Fuster D et al (2009) 2009 EANM parathyroid guidelines. Eur J Nucl Med Mol Imaging 36:1201–1216
Neumann DR, Esselstyn CB Jr, Go RT et al (1997) Comparison of double-phase 99mTc-sestamibi subtraction SPECT in hyperparathyroidism. AJR Am J Roentgenol 169:1671–1674
Lavely WC, Goetze S, Firedman KP et al (2007) Comparison of SPECT/CT, SPECT and planar imaging with single- and dual-phase 99mTc-sestamibi scintigraphy. J Nucl Med 48:1084–1089
Tunninen V, Varjo P, Schildt J et al (2013) Comparison of five parathyroid scintigraphic protocols. Int J Mol Imaging 2013:921260
Sundin A, Johansson C, Hellman P et al (1996) PET and parathyroid L-[carbon-11] methionine accumulation in hyperparathyroidism. J Nucl Med 37:1766–1770
Otto D, Boemer AR, Hofman M et al (2004) Pre-operative localization of hyperfunctioning parathyroid tissue with 11C-methionine PET. Eur J Nucl Med Mol Imaging 31:1405–1412
Beggs AD, Hain SF (2005) Localization of parathyroid adenomas using 11C-methionine positron emission tomography. Nucl Med Commun 26:133–136
Tang BN, Moreno-Reyes R, Blocklet D et al (2008) Accurate pre-operative localization of pathological parathyroid glands using 11C-methionine PET/CT. Contrast Media Mol Imaging 3:157–163
Traub-Weidinger T, Mayerhoefer ME, Koperek O et al (2014) 11C-methionine PET/CT imaging of 99mTC-MIBI-SPECT/CT-negative patients with primary hyperparathyroidism and previous neck surgery. J Clin Endocrinol Metab 99:4199–4205
Michaud L, Burgess A, Huchet V et al (2014) Is 18F-fluorocholine-positron emission tomography/computerized tomography a new imaging tool for detecting hyperfunctioning parathyroid glands in primary or secondary hyperparathyroidism? J Clin Endocrinol Metab 99:4531–4536
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Schildt, J., Tunninen, V., Seppänen, M., Schalin-Jäntti, C. (2016). Primary Hyperparathyroidism. In: Giovanella, L., Treglia, G., Valcavi, R. (eds) Atlas of Head and Neck Endocrine Disorders. Springer, Cham. https://doi.org/10.1007/978-3-319-22276-9_14
Download citation
DOI: https://doi.org/10.1007/978-3-319-22276-9_14
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-22275-2
Online ISBN: 978-3-319-22276-9
eBook Packages: MedicineMedicine (R0)